We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A mathematical model to estimate the number of cases of variant Creutzfeldt-Jakob Disease (vCJD) that could be caused by transfusions of blood products.
Papers on the transmission of variant Creutzfeldt-Jakob Disease (vCJD) from person to person though donated blood components.
Prevention of CJD and vCJD by the Advisory Committee on Dangerous Pathogens' Transmissible Spongiform Encephalopathy (ACDP TSE) subgroup.
The Commission on Human Medicines (CHM) has concluded that the risk of vCJD cases arising from the use of UK plasma for the manufacture of immunoglobulin medicinal products would be negligible.
The Medicines and Healthcare products Regulatory Agency (MHRA) has undertaken a further review of the safety of albumins manufactured from UK plasma with respect to vCJD.
This paper, including the emerging findings of the appendix prevalence study, was considered at the meeting of the Advisory Committee on Dangerous Pathogens Transmissible Spongiform Encephalopathy Risk Assessment Sub-Group on 14 July 2011.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Paper on the transmission of variant vCJD from person to person though receipt of donated blood components.
(All manufacturers) Potential onward transmission of abnormal prion protein when ultrasound transducer probes with internal lumen during transrectal prostate biopsies on men at risk of vCJD. (MDA/2009/080)
No evidence of any UK clinical cases of variant Creutzfeldt-Jakob Disease (vCJD) being linked to a blood transfusion given after 1999.
Main conclusions reached by independent expert group.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).